The HSCT was able to correct T-cell lymphopenia by expansion of naïve and memory CD4+ T-cells, CD19+ and CD8+, moreover, there was an increase of IgA and IgG2 to normal levels. This evidence concerns the gene CD79A and lymphopenia.